Endovascular interventional therapy in patients with peripheral arterial occlusive disease - Balloon angioplasty;Interventionelle endovaskuläre Therapie bei Patienten mit peripherer arterieller Verschlusskrankheit - Ballonangioplastie

Vasa - Journal of Vascular Diseases

Volumn 33, Issue SUPPL. 64, 2004, Pages 5-7

  Schulte, Karl Ludwig ^a,b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b MARTIN LUTHER KRANKENHAUS   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN;

ANTICOAGULATION; CLINICAL TRIAL; HISTORY; HUMAN; INTERVENTIONAL CARDIOVASCULAR PROCEDURE; INTERVENTIONAL RADIOLOGY; OUTCOMES RESEARCH; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; SHORT SURVEY; TECHNIQUE; TREATMENT INDICATION;

EID: 1542344889     PISSN: 03011526     EISSN: None     Source Type: Journal    
DOI: 10.1024/0301-1526.33.s64.5     Document Type: Short Survey

References (11)

1. Cejna M, Thurnher S, Illiasch H, Horvath W, Waldenberger P, Hornik K, Lammer J. PTA versus Palmaz stent placement in femoropopliteal artery obstruction: a multicenter prospective randomzied study. J Vasc Intervent Radiol 2001; 12: 23-31.
2. Dotter CT and Judkins MP. Transluminal treatment of arteriosclerotic obstruction. Circulation 1964; 30: 654-70.
3. Grimm J, Müller-Hülsbeck S, Jahnke T, Hilbert C, Brossmann J, Heller M. Randomized study to compare PTA alone versus PTA with Palmaz stent placement for femoropopliteal lesions. J Vasc Interv Radiol 2001; 12: 935-41.
4. Grüntzig A, Hopff H. Perkutane Rekanalisation chronischer arterieller Verschlüsse mit einem neuen Dilatationskatheter. Dtsch med Wschr 1974; 99: 2502-10.
5. Hunink MGM, Wong JB, Donaldson MC, Meyerovitz MF, de Vries J, Harrington DP. Revascularization for femoropopliteal disease. A decision and cost-effectiveness analysis. JAMA 1995; 274:165-71.
6. Hunink MGM, Wong JB, Donaldson MC, Meyerovitz MF, de Vries J, Harrington DP. Patency results of percutaneous and surgical revascularization for femoropopliteal arterial disease. Med Decis Making 1994; 14: 71-81.
7. Minar E, Pokrajac B, Maca T, Ahmadi R, Fellner C, Mittlbock M, Seitz W, Wolfram R, Potter R. Endovascular brachytherapy for prophylaxis of restenosis after femoropopliteal angioplasty: results of a prospective randomized study. Circulation 2000; 102: 2694-9.
8. Muradin GS, Bosch JL, Stijnen T, Hunink MG. Balloon dilatation and stent implatation for treatment of femoropopliteal arterial disease: meta-analysis. Radiology 2001; 221: 137-45.
9. Vroegindeweij D, Louwerens DV, Tielbeek AV, Buth J, v.d. Bosch HCM. Balloon angioplasty combined with primary stenting versus balloon angioplasty alone in femoropopliteal obstructions: a comparative randomized trial. Cardiovasc Intervent Radiol 1997; 20: 420-5.
10. Wagner H-J. Zum aktuellen Stellenwert der endovaskulären Therapie im femoropoplitealen GefäBabschnitt bei chronischer pAVK. VASA 2002; 31: 153-161.
11. Working Group RB. Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC). Inter Angiol 2000; 19: 1-310.